[Tuesday, 12th Jul 2022 - Wednesday, 13th Jul 2022 ]
DIA CoRE Singapore Annual Meeting 2022: Aspirations for the Future of Healthcare
Grand Copthorne Waterfront Hotel, 392 Havelock Road, Singapore

This year we, DIA and CoRE are celebrating the 5th Anniversary of our joint annual meeting on 12-13 July 2022, where industry experts and health authorities from Asia-Pacific meet at the Singapore Annual Meeting. This meeting is in a hybrid format.

The COVID-19 pandemic has ushered an increased speed of healthcare innovations with the hope of effectively managing this public health threat. This meeting offers a neutrally organized forum to discuss lessons learned and better prepare the healthcare system for the next challenges. From 12-13 July, representatives from health authorities and industry leaders meet in person for the first time in two years to foster positive changes in the healthcare environment in the Asia-Pacific.

For this 5th edition the committee and DIA team has put together an agenda with cutting-edge topics which will instigate to open dialogue around:

  • Current Asia Pacific and global regulatory landscape;

  • Emerging technology and methodologies in drug development;

  • Policy, regulatory and infrastructure considerations to fulfil the potential of data use and digital technologies;

  • Digital health, telemedicine, personalised and integrated care, and the degree of adoption and application in Asia Pacific;

  • Approaches in Balancing Science and Operations for Better Access;

  • Adoption of DCTs, the challenges faced and what the future holds for DCT in Asia Pacific region;

  • Regulatory convergence, reliance and alternative pathways;

  • Patient centricity and patient-centric health systems that includes emerging technologies, innovations in cancer care, digital health and improved patient access to novel therapies.

Key Speakers:

  • Raymond CHUA, Deputy Director - Medical Services Health Regulation Group Ministry of Health Singapore

  • Andrew Pengilley, Senior Medical Advisor, TGA

  • Ahn Bourcet Nguyen, Director - Market Access, Public Health Policy, Diagnostics (APAC),  Abbott

  • Serena Chan, Executive Director-Clinical Operations, Syneos Health Singapore Pte Ltd.

  • Ralf ALTENBURGER, Global Head Cell and Gene Therapy and Global Head Pharma Technical Regulatory F. Hoffmann La-Roche Ltd. Basel

  • Shin-ichi Okudaira, Deputy Review Director - Office of Cellular and Tissue-based Products, PMDA

  • Fatemeh Razjouyan, Director of Regulatory Policy -International and Harmonization, Global Regulatory Policy, Medtronic

  • Daniela Caiazza, Senior Director - Clinical Services, Novotech

  • Yu LIANG -Associate Director Regulatory Affairs APAC, MSD – Singapore

  • Jesusa Joyce N. CIRUNAY, RPh Director IV, Center for Drug Regulation and Research, Food and Drug Administration Philippines Civic Drive, Filinvest Corporate City Alabang, Muntinlupa City, Philippines